Organon shareholders approve Sun Pharma's $11.75 billion acquisition
after close1 source ↓written by the desknot a recommendation
- proposal valued
- $11.75 billion
Sun Pharmaceutical Industries Ltd announced that Organon shareholders approved its acquisition proposal valued at $11.75 billion. This approval is a significant step towards finalizing the transaction, which remains subject to customary closing conditions and regulatory approvals. Once completed, Organon will become a wholly owned subsidiary of Sun Pharma's US entity.
Not investment advice. For informational purposes only.